ACLARIS THERAPEUTICS INC (ACRS) Stock Balance Sheet
NASDAQ:ACRS - Nasdaq - US00461U1051 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 47.65M | 39.88M | 45.30M | 27.30M | 22.10M | |||
| Marketable Securities | 80.07M | 79.23M | 172.30M | 164.10M | 32.10M | |||
| Receivables | 343.00K | 298.00K | 500.00K | 600.00K | 800.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 4.26M | 9.45M | 13.50M | 13.00M | 2.60M | |||
| Total Current Assets | 132.33M | 128.86M | 231.60M | 205.00M | 57.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.11M | 5.48M | 3.80M | 4.80M | 5.80M | |||
| Investments And Advances | 45.71M | 62.77M | 12.20M | 34.20M | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | 269.00K | 7.00M | 7.00M | 7.10M | |||
| Other Non-Current Assets | 243.00K | 30.00K | 100.00K | 100.00K | 400.00K | |||
| Total Non-Current Assets | 50.06M | 68.55M | 23.00M | 46.20M | 13.30M | |||
| TOTAL ASSETS | 182.39M | 197.41M | 254.60M | 251.20M | 70.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 4.19M | 12.93M | 6.00M | 5.10M | 4.60M | |||
| Accounts Payable | 7.66M | 8.88M | 10.40M | 10.00M | 5.30M | |||
| Other Current Liabilities | 6.96M | 9.15M | 5.60M | 7.90M | 5.00M | |||
| Total Current Liabilities | 18.82M | 30.95M | 21.90M | 22.90M | 14.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 10.70M | |||
| Deferred Taxes/Income | N/A | 0.00 | 400.00K | 400.00K | 400.00K | |||
| Other Non-Current Liabilities | 33.43M | 9.27M | 34.70M | 30.60M | 7.20M | |||
| Total Non-Current Liabilities | 33.43M | 9.27M | 35.10M | 31.00M | 18.20M | |||
| TOTAL LIABILITIES | 52.24M | 40.23M | 57.00M | 53.90M | 33.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -806.31M | -770.80M | -682.30M | -595.40M | -504.50M | |||
| Additional Paid In Capital | 936.03M | 928.08M | 880.80M | 793.00M | 542.30M | |||
| Common Shares | 1.00K | 1.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 427.00K | -106.00K | -900.00K | -200.00K | -100.00K | |||
| Shares Outstanding | 71.42M | 70.89M | 66.70M | 61.20M | 45.10M | |||
| Tangible Book Value per Share | 1.82 | 2.21 | 2.86 | 3.11 | 0.68 | |||
| Total Shareholders' Equity | 130.15M | 157.18M | 197.60M | 197.30M | 37.70M | |||
| TOTAL LIABILITIES AND EQUITY | 182.39M | 197.41M | 254.60M | 251.20M | 70.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.28 | |||
| Current Ratio | 7.03 | 4.16 | 10.58 | 8.95 | 3.86 | |||
| Return On Assets (ROA) | -20.29% | -44.82% | -34.14% | -36.17% | -72.06% | |||
| Return On Equity (ROE) | -28.43% | -56.29% | -43.98% | -46.06% | -135.33% | |||
All data in USD , ROIC based on taxRate of 0.21